36C24827Q0037.docx

DOCX document 24 KB Posted

Attached to
S299--FY27 Pharmaceutical Reverse Distribution Services
Solicitation number
36C24827Q0037
Issued by

About this file

This is a Sources Sought Notice for market research issued by the Department of Veterans Affairs Network Contracting Office 8 (NCO 8) at the Orlando VA Healthcare System. The Orlando VA Health Care System (OVAHCS) is seeking to identify qualified contractors to provide pharmaceutical reverse distribution and destruction services for controlled (Schedules I-V) and non-controlled medications across multiple facility locations in Florida. The contractor must be DEA-licensed and capable of collecting, transporting, reverse distributing, and destroying expired, recalled, or unusable medications while maintaining full lifecycle accountability and recovering manufacturer credits for eligible non-controlled substances. Services will be provided across five locations: Orlando VAMC (inpatient and outpatient), Lake Baldwin VA Clinic, Daytona Beach VA Clinic, and Viera VA Clinic, with a minimum of four on-site visits per calendar year plus additional visits as directed. The contractor must provide chain-of-custody documentation, DEA Form 41 processing, a web-based service request system and reporting portal, toll-free support, manufacturer return coordination, and DSCSA compliance. Fees must be structured as flat-fee services and cannot be calculated as a percentage of credit returns.

Responses to this market research notice are due by November 18, 2026, at 3:00 PM Eastern Time and must not exceed ten pages excluding licenses and certifications. Interested sources should submit a capabilities statement addressing company information and socioeconomic status, technical capability, past performance (up to two examples from the last five years), relevant federal contract vehicles, and small business participation plans. The anticipated award date is approximately December 2026, with a period of performance consisting of one base year plus two optional 12-month periods. The NAICS code is 562119 with a 250-employee size standard. This notice is for market research purposes only and does not constitute a solicitation or binding obligation; responses should be submitted in Microsoft Word or PDF format to rohan.mckenzie@va.gov with the subject line "Sources Sought Response - [Company Name] - 36C24827Q0037."

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sources Sought Notice Sources Sought Notice

SUBJECT*
FY27 Pharmaceutical Reverse Distribution Services

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
32827
SOLICITATION NUMBER*
36C24827Q0037
RESPONSE DATE/TIME/ZONE
11-18-2026 3:00 PM EASTERN TIME, NEW YORK, USA
ARCHIVE
60 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N

SET-ASIDE

PRODUCT SERVICE CODE*
S299
NAICS CODE*
562119
CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

Network Contracting Office 8 (NCO 8) Orlando VA Healthcare System 13800 Veterans Way Orlando FL 32827

POINT OF CONTACT*

PLACE OF PERFORMANCE

ADDRESS
Department of Veterans Affairs

Orlando VA Healthcare System

13800 Veterans Way

Orlando FL

POSTAL CODE
32827
COUNTRY
USA

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

SOURCES SOUGHT NOTICE

PHARMACEUTICAL REVERSE DISTRIBUTION SERVICES ORLANDO VA HEALTH CARE SYSTEM (OVAHCS)

Notice Type:
Sources Sought (Market Research)
Notice ID:
36C24827Q0037
Agency:
Department of Veterans Affairs
Contracting Office:
Network Contracting Office 8 (NCO 8)
Issuing Office Address:
Orlando VA Healthcare System, 13800 Veterans Way, Orlando, FL 32827
NAICS Code:
562119
Size Standard:
250 Employees
Product/Service Code:
S299 – Housekeeping Other
Place of Performance:
Multiple sites within OVAHCS (Orlando, Daytona Beach, and Viera, FL)
Response Due Date:
November 18, 2026, 3:00 PM

1. DISCLAIMER

THIS IS A SOURCES SOUGHT NOTICE ONLY. This is not a solicitation announcement, a request for proposals, a request for quotes, or an obligation on the part of the Government to acquire any products or services. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. The Government will not pay for any information provided in response to this notice or for the Government's use of such information. All costs associated with responding to this Sources Sought are solely at the responder's expense.

The purpose of this notice is to conduct market research to identify qualified sources — including Service-Disabled Veteran-Owned Small Businesses (SDVOSB), Veteran-Owned Small Businesses (VOSB), and other small business categories — capable of providing the services described herein. Responses will assist the Government in determining the appropriate acquisition strategy, including potential small business set-aside determinations under FAR Part 19 and 38 U.S.C. §§ 8127–8128 (VA Rule of Two).

2. BACKGROUND

The Orlando VA Health Care System (OVAHCS) is required by federal regulation to remove all controlled and non-controlled substances that are expired, recalled, or otherwise determined to be unusable from active stock. These substances must be stored separately until destroyed, reverse distributed, or transferred to a DEA-licensed vendor for destruction, in accordance with 21 CFR Part 1317.

OVAHCS is seeking to expand its current destruction-only capability to include pharmaceutical reverse distribution services for non-controlled substances that would otherwise result in lost manufacturer credit opportunities and incomplete inventory lifecycle control, while maintaining destruction capability for both controlled and non-controlled medications across all OVAHCS sites. The intended outcomes include:

· Recovery of financial credit for eligible non-controlled medications that are reverse distributed.

· Improved inventory management and reduced waste.

· Full lifecycle accountability for all medications.

· Strengthened compliance with VA, DEA, and federal requirements.

3. DESCRIPTION OF REQUIREMENT

The Government is seeking a contractor licensed by the Drug Enforcement Administration (DEA) to provide flat-fee services to collect, transport, reverse distribute, and/or destroy controlled (Schedules I–V) and non-controlled medications at OVAHCS facilities. Fees shall not be calculated as a percentage of credit returns under any circumstances.

3.1 Scope Highlights

The Contractor shall provide:

· On-site processing of Schedule I–V controlled substances and non-controlled substances (including expired, recalled, due-to-expire, or otherwise unusable medications).

· A minimum of four (4) on-site visits per calendar year at the Outpatient Clinics and Orlando VA Medical Center, with additional visits as directed by the COR. Response within ten (10) business days of a COR request.

· All shipping instructions, forms, labels, postage, DEA-approved tamper-proof pouches, and boxes required for shipment to the Contractor's central processing facility.

· Chain-of-custody documentation, including DEA Form 41 for controlled substances, signed by the Pharmacist, Accountable Officer, and Contractor representative.

· Manufacturer return coordination, credit reconciliation, and Drug Supply Chain Security Act (DSCSA) compliance.

· A toll-free (800) number and a web-based service request ordering system.

· A web-based reporting portal that captures collection date, site, drug name, formulation/strength, NDC, quantity, manufacturer, estimated return value, actual return value, and status of each reverse distribution pickup.

· Initial orientation and training on all applicable reports and web-based systems.

· A written Substance Collection Plan and Substance Contingency Plan.

3.2 Applicable Regulatory Framework

The Contractor shall comply with all applicable federal, state, and local regulations, including but not limited to:

· Controlled Substances Act (CSA)

· 21 CFR Part 1317 (DEA regulations for disposal of controlled substances)

· Drug Supply Chain Security Act (DSCSA)

· 21 CFR (Food & Drugs), 29 CFR (Hazardous Materials), 40 CFR (Environment), 49 CFR (Transportation)

· EPA, OSHA, FDA, DEA requirements

· 41 U.S.C. Chapter 67 (Service Contract Labor Standards)

· All applicable VA policies and facility-specific security requirements

3.3 Places of Performance

Facility
Address
City
State
ZIP
Orlando VAMC at Lake Nona – Inpatient
13800 Veterans Way
Orlando
FL
32827
Orlando VAMC at Lake Nona – Outpatient
13800 Veterans Way
Orlando
FL
32827
Lake Baldwin VA Clinic
5201 Raymond Street
Orlando
FL
32803
Daytona Beach VA Clinic
1776 North Williamson Blvd
Daytona Beach
FL
32117
Viera VA Clinic
2900 Veterans Way
Viera
FL
32940

3.4 Historical Collection Frequency

· Orlando VAMC at Lake Nona (Inpatient & Outpatient): Monthly

· Lake Baldwin VA Clinic: Monthly to Quarterly

· Daytona Beach VA Clinic: Monthly to Quarterly

· Viera VA Clinic: Monthly to Quarterly Historically each site received approximately 4–12 collection visits per year. Per-shipment weight data is not available.

3.5 Anticipated Period of Performance

One (1) base year plus two (2) 12-months option periods, anticipated award date is approximately December 2026. Actual periods will be established in the resulting solicitation.

4. INFORMATION REQUESTED FROM RESPONDENTS

Interested and capable sources are requested to submit a capabilities statement not to exceed ten (10) pages (excluding certifications and licensing documentation), addressing the following:

4.1 Company Information

1. Company name, address, point of contact (name, title, phone, email), and Unique Entity Identifier (UEI).

2. Business size and socioeconomic status under NAICS 424210 (Size Standard: 250 employees). Identify all applicable categories:

· Service-Disabled Veteran-Owned Small Business (SDVOSB) – verified in SBA VetCert

· Veteran-Owned Small Business (VOSB) – verified in SBA VetCert

· Women-Owned Small Business (WOSB) / EDWOSB

· HUBZone Small Business

· 8(a) Certified

· Small Business

· Other than Small

3. Confirmation of active registration in the System for Award Management (SAM.gov).

4.2 Technical Capability

Provide a narrative describing the respondent's ability to fulfil the requirement, addressing at minimum:

1. Current DEA registrant status (Schedules II–V) and copies of all applicable DEA registrations.

2. Federal, state, local licenses and permits that are held for the interstate transport, storage, and destruction of controlled and non-controlled hazardous and non-hazardous pharmaceuticals (DEA, DOT, EPA, FDA, OSHA, and applicable state authorities).

3. Description of the respondent's central processing/destruction facility, including environmental and hazardous waste compliance systems.

4. Approach to on-site collection, chain of custody, DEA Form 41 processing, and packaging.

5. Description of the web-based service request ordering system and reporting portal, including reconciliation capabilities for expected vs. received credits.

6. Manufacturer return coordination and credit reconciliation approach, including how credits are routed to the Prime Vendor or the VA.

7. DSCSA compliance approach.

8. Approach to responding within ten (10) business days of a COR service request.

4.3 Past Performance

Provide up to two (2) examples of similar work (federal, state, or commercial) performed within the last five (5) years. For each, include:

· Customer name and point of contact (with current phone/email)

· Contract number (if applicable)

· Period of performance

· Total dollar value

· Brief description of scope, number of sites serviced, and geographic coverage

· Whether the work was performed as prime or subcontractor

4.4 Contract Vehicles

Identify any existing federal contract vehicles under which this requirement could be procured (e.g., GSA Schedule, VA FSS, NASA SEWP, other IDIQ), including contract numbers.

4.5 Small Business Participation

If not a small business, describe anticipated small business subcontracting opportunities and approach for meeting FAR 52.219-9 goals. https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52#FAR_52_219_9

4.6 Market Feedback (Optional but Encouraged)

1. Recommended NAICS code and rationale if different from 424210.

2. Comments on the draft PWS structure, technical feasibility, or ambiguities.

3. Comments on the flat-fee pricing model.

4. Recommended minimum on-site response time.

5. Any concerns regarding the geographic distribution of sites or historical collection frequency.

5. ADDITIONAL INFORMATION

· No solicitation document exists currently.

· The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate.

· Respondents will not be notified of the results of this market research.

· Any resulting solicitation will be publicized separately on SAM.gov (https://sam.gov).

· Questions regarding this notice should be directed via email to the Contract Specialist listed above; questions received by telephone will not receive a response.

6. RESPONSE INSTRUCTIONS

· Format: Microsoft Word or Adobe PDF. Font no smaller than 11-point. Page limit: 10 pages excluding licenses, certifications, and the SAM.gov registration confirmation.

· Subject Line: "Sources Sought Response – [Company Name] – 36C24827Q0037".

· Submit to: rohan.mckenzie@va.gov.

· Response Due: November 18, 2026, EDT.

· Responses received after the due date and time may not be considered. Telephonic responses will not be accepted. Proprietary information should be clearly marked.

*= Required Field
Sources Sought Notice

Sources Sought Notice

File details come from the government source that posted it. Updated .